Article
Public, Environmental & Occupational Health
G. Vallecillo, R. Perello, R. Guerri, F. Fonseca, M. Torrens
Summary: In a study on the impact of COVID-19 on patients with substance use disorders, it was found that 66.6% of the patients had comorbidities associated with COVID-19 risk. Although some patients developed severe pneumonia or acute respiratory distress syndrome, no deaths were reported.
JOURNAL OF PUBLIC HEALTH
(2021)
Article
Clinical Neurology
Giulia Menculini, Luca Steardo, Norma Verdolini, Federica Cirimbilli, Patrizia Moretti, Alfonso Tortorella
Summary: The comorbidity of substance use disorders (SUD) and bipolar disorders (BD) has significant clinical implications. BD patients with SUD demonstrated earlier onset, higher clinical severity, and poorer treatment response. Logistic regression revealed a positive association between SUD and BD type I diagnosis and mixed features.
JOURNAL OF AFFECTIVE DISORDERS
(2022)
Article
Behavioral Sciences
Shaoru Zhang, Aiqun Liu, Zhihua Zhou, Zheng Huang, Jing Cheng, Danping Chen, Qizhi Zhong, Qingyun Yu, Zhongxing Peng, Mingfan Hong
Summary: This study found that patients with dystonia in WD are usually accompanied by low BMI, anxiety, depression, apraxia, executive dysfunction, dysarthria, and dysphagia. Their cortical activities appeared to be more chaotic during eyes-closed and reading tasks, but lower during swallowing stages compared to the control group.
BRAIN AND BEHAVIOR
(2022)
Review
Psychiatry
Octavian Vasiliu
Summary: This systematic literature review evaluated the efficacy and tolerability of psychobiotics in patients with psychiatric disorders. The study found potential benefits of psychobiotics in mood disorders, ADHD, and ASD. However, further research is needed to establish specific clinical recommendations for different psychiatric disorders and populations.
FRONTIERS IN PSYCHIATRY
(2023)
Review
Clinical Neurology
Sara Maria Pani, Luca Saba, Matteo Fraschini
Summary: This mini-review summarizes recent clinical findings related to the analysis of the aperiodic component of EEG power spectra. The studies focus on exploring the pathophysiological significance of the aperiodic component and its correlation with disease presence, stage, and severity. The findings support the role of the aperiodic activity as an index of excitation/inhibition balance with promising clinical applications.
CLINICAL NEUROPHYSIOLOGY
(2022)
Article
Health Care Sciences & Services
Binh Nguyen, Chenyue Zhao, Eric Bailly, Winnie Chi
Summary: This study examines the characteristics of patients initiating buprenorphine treatment via telehealth and its association with treatment outcomes and health outcomes. The findings suggest that telehealth-initiated buprenorphine treatment is associated with reduced opioid overdose rate and improved patient engagement.
JOURNAL OF GENERAL INTERNAL MEDICINE
(2023)
Article
Neurosciences
Shabah M. Shadli, Robert G. Delany, Paul Glue, Neil McNaughton
Summary: Anxiety disorders are the most prevalent mental disorders in the world, causing significant economic burdens and reducing quality of life. Ketamine has been found to be an effective anxiolytic, even in cases resistant to conventional treatments, but its therapeutic mechanism is still unknown.
FRONTIERS IN NEUROSCIENCE
(2022)
Article
Psychiatry
Shashwat Kala, Max J. Rolison, Dominic A. Trevisan, Adam J. Naples, Kevin Pelphrey, Pamela Ventola, James C. McPartland
Summary: This study found that after 16 weeks of behavioral treatment, the N170 could serve as an objective index of treatment response in children with Autism Spectrum Disorder (ASD). No change in N170 latency was observed in the waitlist control condition. Future larger studies are needed to confirm whether the N170 may be useful as a biomarker of treatment response.
FRONTIERS IN PSYCHIATRY
(2021)
Review
Neurosciences
Francesc Casanovas, Francina Fonseca, Anna Mane
Summary: Women with schizophrenia or other psychotic disorders have different patterns of substance use and substance use disorders compared to men. Substance use and substance use disorders are less common in women, but may be underdiagnosed. Substance use, especially cannabis, may have a more negative impact on the disease course and prognosis in female patients. Treating substance use disorders in female patients with schizophrenia may be more challenging and have a negative impact on prognosis.
CURRENT NEUROPHARMACOLOGY
(2023)
Article
Medicine, General & Internal
Jessica Irving, Craig Colling, Hitesh Shetty, Megan Pritchard, Robert Stewart, Paolo Fusar-Poli, Philip McGuire, Rashmi Patel
Summary: The study found that men with first episode psychosis were more likely to present negative, disorganised, depressive and manic symptoms, while women were more likely to present tearfulness, low mood, and reduced appetite. Gender differences in symptom presentation were influenced by illicit substance use, but not completely explained by it.
Article
Medicine, General & Internal
Els Santens, Geert Dom, Eva Dierckx, Laurence Claes
Summary: This study investigates the relationship between reactive and regulative temperament, clinical symptomatology, and personality disorders in patients with substance use disorder (SUD). The results suggest that low levels of effortful control (EC) are related to psychopathology in adults with SUD. Strengthening EC through therapeutic interventions may lead to improved treatment outcomes for addiction and comorbid psychopathology.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Neurosciences
Hikmat Hadoush, Ashraf Hadoush
Summary: This randomized controlled trial examined the effects of bilateral anodal tDCS stimulation over cerebellar hemispheres on resting-state brain complexity in children with Autism Spectrum Disorders (ASD). The results showed that the tDCS stimulation significantly increased brain complexity in the right frontal cortical region. This study suggests that the cerebellum and cerebellar-cerebral circuitry could be a promising target for non-invasive brain stimulation and neuro-modulation as a therapeutic intervention for ASD.
Article
Clinical Neurology
Lucy A. Chester, Lucia R. Valmaggia, Matthew J. Kempton, Edward Chesney, Dominic Oliver, Emily P. Hedges, Elise Klatsa, Daniel Stahl, Mark van der Gaag, Lieuwe de Haan, Barnaby Nelson, Patrick McGorry, G. Paul Amminger, Anita Riecher-Rossler, Erich Studerus, Rodrigo Bressan, Neus Barrantes-Vidal, Marie-Odile Krebs, Birte Glenthoj, Merete Nordentoft, Stephan Ruhrmann, Gabriele Sachs, Philip McGuire
Summary: The aim of this study was to investigate the association between cannabis use and the incidence of psychotic disorders in individuals at clinical high risk of psychosis. The results showed no significant association between cannabis use and the transition to psychosis, persistence of symptoms, or functional outcome.
PSYCHIATRY AND CLINICAL NEUROSCIENCES
(2023)
Article
Clinical Neurology
Noriyuki Miyaue, Yuko Hosokawa, Yuki Yamanishi, Satoshi Tada, Rina Ando, Masahiro Nagai
Summary: CSF neopterin levels can distinguish between different CNS demyelinating diseases and may be useful for differential diagnosis and assessment of disease activity. Further studies are needed to validate its utility and compare with other biomarkers.
JOURNAL OF THE NEUROLOGICAL SCIENCES
(2022)
Article
Medicine, General & Internal
Viviana E. Horigian, Renae D. Schmidt, Dikla Shmueli-Blumberg, Kathryn Hefner, Judith Feinberg, Radhika Kondapaka, Daniel J. Feaster, Rui Duan, Sophia Gonzalez, Carly Davis, Rodrigo Marin-Navarrete, Susan Tross
Summary: The current research assessed the role of suicidality as a predictor of overdose events in individuals with substance use disorder. The study found that higher suicidality scores were associated with an increased likelihood of overdose. Participants with a history of heroin use were more likely to experience overdose events. These findings highlight the importance of incorporating suicide risk reduction as part of prevention strategies for overdose deaths.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Audiology & Speech-Language Pathology
Alejandro Torres-Fortuny, Heivet Hernandez-Perez, Belinda Ramirez, Ileana Alonso, Eduardo Eimil, Alioth Guerrero-Aranda, Eleina Mijares
INTERNATIONAL JOURNAL OF AUDIOLOGY
(2016)
Article
Clinical Neurology
Alioth Guerrero-Aranda, Henry Friman-Guillen, Andres Antonio Gonzalez-Garrido
Summary: The use of standardized computer-based organized reporting of EEG (SCORE) as a format for EEG reports has been endorsed by the International Federation of Clinical Neurophysiology (IFCN). This study aimed to assess the acceptability of this proposed format among end-users. The survey results showed that most physicians prefer the standardized format and find it acceptable.
CLINICAL EEG AND NEUROSCIENCE
(2023)
Article
Clinical Neurology
Alioth Guerrero-Aranda, Andrea Enriquez-Zaragoza, Karla Lopez-Jimenez, Andres Antonio Gonzalez-Garrido
Summary: The effectiveness of sleep deprivation EEG (sdEEG) in the diagnostic process of patients with suspected epilepsy has not been fully clarified. This study found no significant difference in the yield of sdEEG compared to routine EEG in confirming epilepsy in patients.
CLINICAL EEG AND NEUROSCIENCE
(2022)
Article
Neurosciences
Alioth Guerrero-Aranda, Evelin Ramirez-Ponce, Oscar Ramos-Quezada, Omar Paredes, Erick Guzman-Quezada, Alejandra Genel-Espinoza, Rebeca Romo-Vazquez, Hugo Velez-Perez
Summary: This study investigates the differences in EEG spectral dynamics and entropy patterns during different periods of absence seizures. The findings suggest that delta and theta power increase significantly in the pre-ictal and post-ictal intervals, especially in the posterior brain region. Additionally, there is a notable decrease in entropy in the pre-ictal and post-ictal intervals, especially in anterior brain regions. These results provide valuable information for distinguishing epileptiform patterns in typical absence seizures.
FRONTIERS IN HUMAN NEUROSCIENCE
(2023)
Article
Neurosciences
Alioth Guerrero-Aranda, Francisco J. Taveras-Almonte, Fridha V. Villalpando-Vargas, Karla Lopez-Jimenez, Gloria M. Sandoval-Sanchez, Julio Montes-Brown
Summary: This study investigates the impact of ambulatory electroencephalography (AEEG) monitoring on patients with suspected or confirmed epilepsy in two resource-limited Latin American countries. The results show that AEEG is a valuable tool for assessing epilepsy cases in resource-limited settings and has a significant impact on clinical decision-making.
CLINICAL NEUROPHYSIOLOGY PRACTICE
(2023)
Article
Psychology
Alioth Guerrero-Aranda, Fabiola Reveca Gomez-Velazquez, Andres Antonio Gonzalez-Garrido
ANUARIO DE PSICOLOGIA
(2018)
Article
Otorhinolaryngology
Alioth Guerrero-Aranda, Eleina Mijares-Nodarse, Heivet Hernandez-Perez, Alejandro Torres-Fortuny
INDIAN JOURNAL OF OTOLOGY
(2016)